Trader: Low Volume ...
Health Care: Drugs
Cyclacel Pharmaceuticals Inc. (CYCC: NASDAQ)
$0.52 -0.07 | -11.86%
06/04/12 - 03:59 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -15.24M | -16.02M | -19.57M | -40.38M |
| Operating Gains/Losses | 1.00K | -13.00K | 83.00K | 2.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 577.00K | -3.07M | 514.00K | 0.00 |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | -2.70M |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | 273.00K | 2.08M | 1.37M | 10.95M |
| Net Cash From Continuing Operations | -13.98M | -16.04M | -15.19M | -29.90M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -13.98M | -16.04M | -15.19M | -29.90M |
| Sale of Property, Plant & Equipment | 5.00K | 41.00K | 91.00K | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 1.48M | 30.76M |
| Purchases of Property, Plant & Equipment | -6.00K | -8.00K | -15.00K | -366.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -3.06M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -1.00K | 33.00K | 1.56M | 27.34M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 3.00K | 33.40M | 3.85M | 0.00 |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | -11.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | -364.00K | 0.00 | 0.00 | -1.23M |
| Other Financing Charges, Net | 9.27M | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 8.91M | 33.40M | 3.85M | -1.24M |
| Effect of Exchange Rate Changes | 26.00K | 617.00K | -2.94M | -2.97M |
| Net Change in Cash & Cash Equivalents | -5.05M | 18.00M | -12.73M | -6.76M |
Portfolios with CYCC
- Portfolio NameUser Type
- Uservlady 1
- Contributor13 Biotech Stocks Bought an...
- ProWilbur Ross - Invesco Priva...
- Contributor10 Cheap Biotech Stocks Tha...
- Userjeezlola
- Contributor10 Biotech Stocks Expected ...
- UserJSD Holdings
- UserBesV Portfolio 1
- UserStock2009
- UserTdawg
Latest CYCC Headlines from TheStreet
- Friday's Top 10 Articles, Videos on TheStreet 03.02.12 | 01:03 pm
- Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash 03.02.12 | 05:03 am
- BIO CEO Conference Live Blog 02.13.12 | 01:02 pm
- The Worst Biotech CEO of 2011 Is ... 12.09.11 | 07:12 am
- The Biotech Stock 13F Review: What Hedge Funds Were Buying and Selling 11.16.11 | 08:11 am
- Biotech Stock Mailbag: Somaxon, Transcept 10.07.11 | 06:10 am
- Biotech Stock Mailbag: Research Backs Shorting Micro-Cap Cancer Drug Stocks 09.30.11 | 05:09 am
- Biotech Stock Mailbag: Cyclacel Pharma 08.12.11 | 05:08 am
- Cyclacel Stock Gaps Down On Today's Open (CYCC) 08.08.11 | 10:08 am
- Biotech Stock Mailbag: Ranking Cheap Biotechs 07.01.11 | 08:07 am
Press Releases for CYCC
Partner Headlines for CYCC
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 - Seeking Alpha 05.25.12 | 08:05 pm
- Cyclacel: An Intriguing Long Shot - Seeking Alpha 03.20.12 | 08:03 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 11.18.11 | 09:11 am
- Buy And Sell Ideas Based On Wednesday's Big News And Price Decliners - Seeking Alpha 09.29.11 | 08:09 am
- The Biotech Bump: Cyclacel Pharmaceuticals - Benzinga 07.28.11 | 01:07 pm
- Profit From These 3 Analysts' Stock Picks for Under $10 - Seeking Alpha 07.13.11 | 09:07 am
- Cyclacel Pharmaceuticals Files S-3 $75M Mixed Securities Shelf - Benzinga 04.04.11 | 04:04 pm
- US scientists recreate heart defect in a lab dish - Reuters 02.09.11 | 01:02 pm
- Pfizer, Adolor End Collaboration to Develop Pain Meds: Biotech's Latest Troubles - Seeking Alpha 12.26.10 | 01:12 am
